Search results

Articles (6)

Journals (0)

1-6 of 6 results for flat-dose immunotherapy

Sort by:

Relevance

Select all

Sort by:

Relevance

Retricted accessResearch articleFirst published 2026

Rethinking centralised oncology pharmacy practice in the era of flat-dose immunotherapy,subcutaneous formulations and visit-administration day separation: A conceptual analysis and reform proposal

Mauro Iannopollo

Journal of Oncology Pharmacy Practice

Retricted accessArticle commentaryFirst published June, 2019

Efficacy of nivolumab four-weekly dosing schedule based on body weight

Mário L de Lemos, Carrie Kung, Sally Waignein

Journal of Oncology Pharmacy Practice

Retricted accessLetterFirst published 2026

The French Society for Pharmacy Oncology's commentary on the article by Iannopollo M.,published in April 2026 and titled “Rethinking centralised oncology pharmacy practice in the era of flat-dose immunotherapy,subcutaneous formulations and visit-administration day separation: A conceptual analysis and reform proposal”

Florence Ranchon, Nicolas Cormier, Jean-Louis Cazin [...]

Journal of Oncology Pharmacy Practice

Open accessResearch articleFirst published October, 2025

Evaluation of safety outcomes between nivolumab regimens with differing dosing patterns

Joseph Elijah, Igor Puzanov, Benjamin Cresanti [...]

Journal of Oncology Pharmacy Practice

Retricted accessCase reportFirst published April, 2024

Nivolumab treatment in a patient with BRAF mutant advanced melanoma and liver failure with encephalopathy

Rumeysa Colak, Caner Kapar, Ilkay Gulturk [...]

Journal of Oncology Pharmacy Practice

Open accessResearch articleFirst published 2025

Rationale and design for a phase IIIb trial of first-line tremelimumab plus durvalumab versus pembrolizumab,in combination with chemotherapy,in patients with non-squamous metastatic non-small-cell lung cancer and mutations or co-mutations in STK11,KEAP1,or KRAS : the TRITON study

Ferdinandos Skoulidis, Hossein Borghaei, Edward B. Garon [...]

Therapeutic Advances in Medical Oncology

Search results

Articles (6)

Journals (0)

1-6 of 6 results for flat-dose immunotherapy

Sort by:

Relevance

Select all

Sort by:

Relevance

Retricted accessResearch articleFirst published 2026

Rethinking centralised oncology pharmacy practice in the era of flat-dose immunotherapy,subcutaneous formulations and visit-administration day separation: A conceptual analysis and reform proposal

Mauro Iannopollo

Journal of Oncology Pharmacy Practice

Retricted accessArticle commentaryFirst published June, 2019

Efficacy of nivolumab four-weekly dosing schedule based on body weight

Mário L de Lemos, Carrie Kung, Sally Waignein

Journal of Oncology Pharmacy Practice

Retricted accessLetterFirst published 2026

The French Society for Pharmacy Oncology's commentary on the article by Iannopollo M.,published in April 2026 and titled “Rethinking centralised oncology pharmacy practice in the era of flat-dose immunotherapy,subcutaneous formulations and visit-administration day separation: A conceptual analysis and reform proposal”

Florence Ranchon, Nicolas Cormier, Jean-Louis Cazin [...]

Journal of Oncology Pharmacy Practice

Open accessResearch articleFirst published October, 2025

Evaluation of safety outcomes between nivolumab regimens with differing dosing patterns

Joseph Elijah, Igor Puzanov, Benjamin Cresanti [...]

Journal of Oncology Pharmacy Practice

Retricted accessCase reportFirst published April, 2024

Nivolumab treatment in a patient with BRAF mutant advanced melanoma and liver failure with encephalopathy

Rumeysa Colak, Caner Kapar, Ilkay Gulturk [...]

Journal of Oncology Pharmacy Practice

Open accessResearch articleFirst published 2025

Rationale and design for a phase IIIb trial of first-line tremelimumab plus durvalumab versus pembrolizumab,in combination with chemotherapy,in patients with non-squamous metastatic non-small-cell lung cancer and mutations or co-mutations in STK11,KEAP1,or KRAS : the TRITON study

Ferdinandos Skoulidis, Hossein Borghaei, Edward B. Garon [...]

Therapeutic Advances in Medical Oncology